MIMEDX to Participate at Upcoming Investor Conferences

MARIETTA, Ga., May 10, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer, and Peter M. Carlson, Chief Financial Officer, will be participating in the following virtual investor conferences:

• Bank of America Securities 2021 Virtual Health Care ConferencePresentation: Thursday, May 13, 2021 at 2:45 PM ETWebcast: Click here to access

• Canaccord Genuity Virtual Musculoskeletal ConferenceFireside Chat: Thursday, May 20, 2021 at 10:00 AM ETWebcast: Click here to access

Institutional investors interested in meeting with management may contact their respective Bank of America or Canaccord Genuity representative.

A live webcast of both presentations will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com or through the conference site by using the links above. A replay will be available on the Company’s website following the event.

About MIMEDXMIMEDX is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MIMEDX has supplied over two million allografts, through both direct and consignment shipments. For additional information, please visit www.MIMEDX.com.

Contacts:InvestorsJack Howarth404-360-5681[email protected]

You May Also Be Interested In

• Crypto News: Moonberg Crypto Presale Sells Out Stage 1 As Bitcoin Price Prediction Faces $65,000 Test
• Chemtrade Logistics Income Fund Announces Results for the Second Quarter of 2026 and Reiterates 2026 Adjusted EBITDA Guidance of $485 to $525 Million
• Diversified Royalty Corp. Announces Second Quarter 2026 Results